HBV vaccines and methods treating HBV
US12364751B2 · kind B2 · utility
0Cited by
44References
53Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 15, 2023 |
| Grant date | Jul 22, 2025 |
| Priority date | — |
| Expiry date | Jun 15, 2043 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are HBV immunogenic polypeptides, polynucleotides encoding such polypeptides, vectors expressing such immunogenic polypeptides for use in eliciting an immune response against HBV; pharmaceutical and immunogenic compositions and kits comprising such polypeptides, polynucleotides or vectors, and methods of use in treating and/or preventing HBV.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.